» Articles » PMID: 34114073

[Evidence on the Effects of Crisis Resolution Teams, Home Treatment and Assertive Outreach for People with Mental Disorders in Germany, Austria and Switzerland - a Systematic Review]

Overview
Journal Nervenarzt
Specialty Neurology
Date 2021 Jun 11
PMID 34114073
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Based on international randomized controlled trials (RCT) the German Association for Psychiatry, Psychotherapy and Psychosomatics (DGPPN) recommends acute treatment in the domestic environment (AHU) and intensive outreach treatment (IAB) with the highest level of evidence; however, due to large differences in national healthcare systems the transference of results from international studies to the healthcare systems in Germany, Austria and Switzerland could be limited.

Objective: Evaluation of studies on outreach psychiatric treatment forms in Germany, Austria and Switzerland and discussion of the results in the light of international evidence.

Material And Methods: A systematic literature search for clinical trials on outreach community treatment from Germany, Austria and Switzerland was conducted in the PubMed database.

Results: A total of 19 publications were identified which could be assigned to 5 publications on 4 studies with 2857 patients on AHU and 14 publications on 10 studies with 3207 patients on IAB. The studies on AHU showed this treatment form to be superior regarding the duration of inpatient stay and healthcare costs. The studies on IAB showed more positive outcomes in comparison to controls regarding symptoms, severity of illness, substance abuse, functioning level, remission, satisfaction with treatment, quality of life, healthcare costs, work and housing situations.

Conclusion: The studies from Germany, Austria, and Switzerland suggest that outreach community treatment is superior regarding several outcome parameters. Thus, there are no indications suggesting that international evidence could not be valid for these countries. Additionally, with one RCT for AHU and one for IAB the requirements for an evidence level of 1b for outreach community treatment in the healthcare systems in question are fulfilled.

Citing Articles

Efficacy of home-based and inpatient treatment for children and adolescents in psychiatric crisis: A systematic review protocol.

Foremnik K, Sroczynski G, Stratil J, Neumann A, Buchberger B PLoS One. 2025; 20(3):e0318792.

PMID: 40063892 PMC: 11893119. DOI: 10.1371/journal.pone.0318792.


Utilization of Psychiatric Hospital Services Following Intensive Home Treatment: A Nonrandomized Clinical Trial.

Bechdolf A, Nikolaidis K, von Peter S, Langle G, Brieger P, Timm J JAMA Netw Open. 2024; 7(11):e2445042.

PMID: 39546314 PMC: 11568461. DOI: 10.1001/jamanetworkopen.2024.45042.


Work-related participation impairments and support needs of patients in a Swiss psychiatric university hospital.

Hug N, Imfeld L, Holinger B, Jackel D, Huber C, Nienaber A Front Psychiatry. 2024; 14:1232148.

PMID: 38239903 PMC: 10794531. DOI: 10.3389/fpsyt.2023.1232148.

References
1.
Estcourt L, Stanworth S, Doree C, Hopewell S, Murphy M, Tinmouth A . Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev. 2012; (5):CD004269. DOI: 10.1002/14651858.CD004269.pub3. View

2.
Dieterich M, Irving C, Bergman H, Khokhar M, Park B, Marshall M . Intensive case management for severe mental illness. Cochrane Database Syst Rev. 2017; 1:CD007906. PMC: 6472672. DOI: 10.1002/14651858.CD007906.pub3. View

3.
Fischer F, Hoffmann K, Monter N, Walle M, Beneke R, Negenborn S . [Cost evaluation of a model for integrated care of seriously mentally ill patients]. Gesundheitswesen. 2013; 76(2):86-95. DOI: 10.1055/s-0033-1343438. View

4.
Baumgardt J, Schwarz J, Bechdolf A, Nikolaidis K, Heinze M, Hamann J . Implementation, efficacy, costs and processes of inpatient equivalent home-treatment in German mental health care (AKtiV): protocol of a mixed-method, participatory, quasi-experimental trial. BMC Psychiatry. 2021; 21(1):173. PMC: 8008509. DOI: 10.1186/s12888-021-03163-9. View